Clinical Trials Browser

NSCLC × S 1 (combination) × 1 year × Clear all

NCT05773092 2025-09-03

A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC

Phase 2 Active not recruiting

NSCLC